Lexicon Pharmaceuticals, Inc. announced the appointment of Scott M. Coiante as senior vice president, effective, January 2, 2025. Mr. Coiante, 58, is a senior finance executive with more than 35 years of experience in the life science and pharmaceutical industries. He joins Lexicon from Agile Therapeutics, where he served as the senior vice president, chief financial officer and treasurer of Agile Therapeutics Inc. from August 2023 to August 2024, as well as from 2011-2019.
During his tenure at Agile Therapeutics, Mr. Coiante was responsible for all financial activities, including supporting business development and fundraising activities. Mr. Coiante also previously served as senior vice president, chief financial officer, treasurer and secretary at Aprea Therapeutics and held several senior financial positions at Medarex Inc., where he supported the transition following the company?s acquisition by Bristol-Myers Squibb and Ernst & Young LLP prior to joining Agile Therapeutics. Mr. Coiante is a certified public accountant and received his B.S. from Villanova University.
In connection with such appointment, Kristen L. Alexander, the company's vice president, finance and accounting, relinquished her function as the company's principal financial officer. Ms. Alexander will continue her function as the company's principal accounting officer.